Progress towards personalized therapeutics: biologic- and risk-directed therapy for neuroblastoma
Progress towards personalized therapeutics: biologic- and risk-directed therapy for neuroblastoma
About this item
Full title
Author / Creator
Publisher
England: Informa Healthcare
Journal title
Language
English
Formats
Publication information
Publisher
England: Informa Healthcare
Subjects
More information
Scope and Contents
Contents
Neuroblastoma, a tumor of the developing peripheral sympathetic nervous system, is the most common and deadly extracranial solid tumor of childhood. Risk-stratification and risk-adapted therapy play a large role in the modern treatment of neuroblastoma. Recently, through extensive international collaboration, new guidelines for risk stratification...
Alternative Titles
Full title
Progress towards personalized therapeutics: biologic- and risk-directed therapy for neuroblastoma
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_895853564
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_895853564
Other Identifiers
ISSN
1473-7175
E-ISSN
1744-8360
DOI
10.1586/ern.11.103
